The Long and Winding Road: Loop Diuretics in Neonatology.

[1]  E. Jensen,et al.  Loop Diuretics in Severe Bronchopulmonary Dysplasia: Cumulative Use and Associations with Mortality and Age at Discharge. , 2020, The Journal of pediatrics.

[2]  C. Cerini,et al.  Furosemide use in Italian neonatal intensive care units: a national survey , 2020, Italian Journal of Pediatrics.

[3]  B. Poindexter,et al.  Respiratory medication use in extremely premature (<29 weeks) infants during initial NICU hospitalization: Results from the prematurity and respiratory outcomes program , 2019, Pediatric pulmonology.

[4]  M. Laughon,et al.  Furosemide Exposure and Prevention of Bronchopulmonary Dysplasia in Premature Infants , 2019, The Journal of pediatrics.

[5]  Prematurity and Respiratory Outcomes Program.  Acute Responses to Diuretic Therapy in Extremely Low Gestational Age Newborns: Results from the Prematurity and Respiratory Outcomes Program Cohort Study. , 2018 .

[6]  T. Raju,et al.  Bronchopulmonary Dysplasia: Executive Summary of a Workshop , 2018, The Journal of pediatrics.

[7]  J. Slaughter,et al.  Variation in the Use of Diuretic Therapy for Infants With Bronchopulmonary Dysplasia , 2013, Pediatrics.

[8]  C. von Schnakenburg,et al.  Exposure to furosemide as the strongest risk factor for nephrocalcinosis in preterm infants , 2010, Pediatrics international : official journal of the Japan Pediatric Society.

[9]  L. Brion,et al.  Diuretics for respiratory distress syndrome in preterm infants. , 2011, The Cochrane database of systematic reviews.

[10]  T. Thompson,et al.  Prophylactic furosemide in severe respiratory distress syndrome: blinded prospective study. , 1988, The Journal of pediatrics.

[11]  B. Clark,et al.  Effect of early furosemide administration in neonates with respiratory distress syndrome , 1987, Pediatric pulmonology.

[12]  T. Hazinski,et al.  Short- and long-term effects of furosemide on lung function in infants with bronchopulmonary dysplasia. , 1986, The Journal of pediatrics.

[13]  J. Brady,et al.  Controlled trial of furosemide therapy in infants with chronic lung disease. , 1985, The Journal of pediatrics.

[14]  J. Lock,et al.  Diuresis and pulmonary function in premature infants with respiratory distress syndrome. , 1983, The Journal of pediatrics.

[15]  W. Fox,et al.  Changes in pulmonary function during the diuretic phase of respiratory distress syndrome. , 1982, The Journal of pediatrics.

[16]  M. Delivoria-Papadopoulos,et al.  Maximum diuresis--a factor in predicting recovery from respiratory distress syndrome and the development of bronchopulmonary dysplasia. , 1981, The Journal of pediatrics.

[17]  A. Stark,et al.  Bronchopulmonary dysplasia: possible relationship to pulmonary edema. , 1978, The Journal of pediatrics.

[18]  A. Wilkinson,et al.  Frusemide in respiratory distress syndrome. , 1975, Archives of Disease in Childhood.

[19]  H. Richardson.  Frusemide in heart failure of infancy , 1971, Archives of disease in childhood.

[20]  W. Northway,et al.  Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. , 1967, The New England journal of medicine.